Headshot portrait of Rosa Bacchetta - Professor (Research) of Pediatrics (Stem Cell Transplantation)
Bio-X Affiliated Faculty

Dr. Rosa Bacchetta's professional goal as a pediatrician specializing in immunology, has been to challenge the limits of "inexplicable" and "untreatable" diseases, and apply current scientific knowledge to understand the mechanisms of impaired cellular immune function underlying the clinical manifestations in order to develop curative treatments.

Following the completion of her pediatrics residency, Dr. Bacchetta received training in molecular and cellular immunology in France (UNICET, Lyon) and the United States (DNAX Research Institute of Molecular and Cellular Biology, Palo Alto) under scientists, who critically influenced my scientific development. There, she was first exposed to the importance of integrating in depth laboratory research with clinical observations to develop a translational research approach to science. Dr. Bacchetta then worked for fifteen years at the San Raffaele Scientific Institute in the Telethon Institute for Gene Therapy (HSR-TIGET), where she focused on dissecting the genetic and immunological basis of primary immunodeficiencies with autoimmune manifestations that might be treated by gene therapy.

In the coming years, Dr. Bacchetta plans to further determine the genetic and immunological basis of diseases with autoimmunity or immune dysregulation in children. She believes that much can still be learned from the in depth mechanistic studies of pediatric autoimmune diseases. Genomic analysis of the patients' samples has become possible which may provide a rapid indication of altered target molecules. Dr. Bacchetta plans to implement robust functional studies to define the consequences of these genetic abnormalities and bridge them to the patient's clinical phenotype.

Understanding functional consequences of gene mutations in single case/family first and then validating the molecular and cellular defects in other patients with similar phenotypes, will anticipate and complement cellular and gene therapy strategies.